As of 2025-07-16, the Relative Valuation of Champions Oncology Inc (CSBR) is 9.06 USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.80 USD, the upside of Champions Oncology Inc based on Relative Valuation is 16.2%.
The range of the Relative Valuation is 7.86 - 16.13 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.6x - 34.7x | 21.6x |
| Forward P/E multiples | 16.9x - 19.5x | 17.4x |
| Fair Price | 7.86 - 16.13 | 9.06 |
| Upside | 0.8% - 106.9% | 16.2% |
| Date | P/E |
| 2025-07-15 | 16.78 |
| 2025-07-14 | 17.15 |
| 2025-07-11 | 17.43 |
| 2025-07-10 | 18.96 |
| 2025-07-09 | 19.17 |
| 2025-07-08 | 18.98 |
| 2025-07-07 | 19.13 |
| 2025-07-03 | 16.53 |
| 2025-07-02 | 16.72 |
| 2025-07-01 | 15.51 |
| 2025-06-30 | 15.86 |
| 2025-06-27 | 16.70 |
| 2025-06-26 | 15.54 |
| 2025-06-25 | 16.29 |
| 2025-06-24 | 16.74 |
| 2025-06-23 | 17.34 |
| 2025-06-20 | 17.84 |
| 2025-06-18 | 18.08 |
| 2025-06-17 | 17.32 |
| 2025-06-16 | 16.38 |
| 2025-06-13 | 16.48 |
| 2025-06-12 | 15.91 |
| 2025-06-11 | 13.49 |
| 2025-06-10 | 13.90 |
| 2025-06-09 | 14.20 |
| 2025-06-06 | 14.83 |
| 2025-06-05 | 13.99 |
| 2025-06-04 | 13.73 |
| 2025-06-03 | 13.84 |
| 2025-06-02 | 12.31 |
| 2025-05-30 | 12.63 |
| 2025-05-29 | 13.30 |
| 2025-05-28 | 12.87 |
| 2025-05-27 | 12.89 |
| 2025-05-23 | 12.48 |
| 2025-05-22 | 12.50 |
| 2025-05-21 | 12.87 |
| 2025-05-20 | 13.34 |
| 2025-05-19 | 12.74 |
| 2025-05-16 | 13.66 |
| 2025-05-15 | 13.51 |
| 2025-05-14 | 13.92 |
| 2025-05-13 | 13.44 |
| 2025-05-12 | 12.91 |
| 2025-05-09 | 13.38 |
| 2025-05-08 | 12.74 |
| 2025-05-07 | 12.50 |
| 2025-05-06 | 12.57 |
| 2025-05-05 | 12.95 |
| 2025-05-02 | 12.42 |